MediXall Group, Inc.
MDXL
$0.0035
$0.00026.06%
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Revenue | 367.82% | 214.90% | 587.50% | 886.08% | 112.73% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 367.82% | 214.90% | 587.50% | 886.08% | 112.73% |
| Cost of Revenue | -33.90% | -17.43% | -68.43% | -76.16% | -51.08% |
| Gross Profit | 47.62% | 36.65% | 77.26% | 81.15% | 58.04% |
| SG&A Expenses | -22.39% | -14.48% | -1.27% | -6.24% | 45.68% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -993.94% |
| Total Operating Expenses | -16.98% | -15.21% | -34.92% | -50.48% | -29.14% |
| Operating Income | 23.09% | 19.63% | 39.10% | 53.55% | 35.82% |
| Income Before Tax | 18.40% | 16.22% | 36.98% | 49.32% | 1.95% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 18.40% | 16.22% | 36.98% | 49.32% | 1.95% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.40% | 16.22% | 36.98% | 49.32% | 1.95% |
| EBIT | 23.09% | 19.63% | 39.10% | 53.55% | 35.82% |
| EBITDA | 23.17% | 19.71% | 39.14% | 53.68% | 37.54% |
| EPS Basic | 25.00% | 23.23% | 40.71% | 51.15% | 9.83% |
| Normalized Basic EPS | 13.58% | 25.86% | 42.86% | 52.67% | 29.57% |
| EPS Diluted | 25.00% | 0.00% | 28.57% | 51.15% | 27.78% |
| Normalized Diluted EPS | 13.58% | 25.86% | 42.86% | 52.67% | 29.57% |
| Average Basic Shares Outstanding | 9.72% | 11.64% | 9.73% | 6.60% | 10.80% |
| Average Diluted Shares Outstanding | 9.72% | 11.64% | 9.73% | 6.60% | 10.80% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
